1. Academic Validation
  2. Novel microbial transformation of resibufogenin by Absidia coerules

Novel microbial transformation of resibufogenin by Absidia coerules

  • Nat Prod Commun. 2011 Nov;6(11):1581-4.
Jian Zheng 1 Dong-Hai Su Dong-Sheng Zhang Xiu-Lan Xin Jun-Ying Liu Yan Tian Qing Wei Xun Cui
Affiliations

Affiliation

  • 1 Division of Chinese Materia Medica & Natural products, National Institute for Control of Pharmaceutical & Biological Products, Beijing 100050, China.
PMID: 22224264
Abstract

Resibufogenin is one of the major active components of the Chinese medicine ChanSu. In this paper, microbial transformation of resibufogenin by Absidia coerules AS 3.3382 was investigated and five metabolites were isolated and identified as 5beta-hydroxy-resibufogenin (2), 3-epi-resibufogenin (3), 3alpha-hydroxy-15-oxo-14alphaH-bufa-20, 22-dienolide (4), 3alpha,14alpha,15beta-trihydroxy-bufa-20, 22-dienolide (5) and 3-epi-15beta-hydroxy-bufalin (6). Among them, 4-6 are novel compounds, and compound 3 is a major transformed product. The cytotoxicities of the compounds against Bel-7402 and Hela cells were investigated, and our result suggested that 14,15-OH configuration was directly related to the cytotoxicities of bufadienolides.

Figures
Products